sp'daily5
Summary
Little to add.
The 200dma of sp'2063 looks an easy target. To me, the only issue is whether we'll get close to the 50dma next week.
--
notable lunch hour spike in Mallinckrodt (MNK), as an equity bio-bear (Mr Left, of Citreon) appears on clown finance TV, only for the market to spike the stock from the 54s to 59s in minutes.
I will only add, I've never traded any bio-stock, I see the whole sector as too crazy for even the best of retail investors. Only a very few companies - of the intl' pharma cartel, are profitable. The rest.... mostly, empty shells.
The ongoing action in Valeant (VRX) remains pretty entertaining though.
---
back at 2pm